KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Exchange Rate Effect (2016 - 2025)

NovoCure (NVCR) has disclosed Exchange Rate Effect for 10 consecutive years, with -$76000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 40.62% to -$76000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $394000.0 through Dec 2025, up 326.44% year-over-year, with the annual reading at $394000.0 for FY2025, 326.44% up from the prior year.
  • Exchange Rate Effect hit -$76000.0 in Q4 2025 for NovoCure, down from -$22000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $265000.0 in Q2 2025 to a low of -$128000.0 in Q4 2024.
  • Historically, Exchange Rate Effect has averaged $3300.0 across 5 years, with a median of -$29500.0 in 2021.
  • Biggest five-year swings in Exchange Rate Effect: crashed 3900.0% in 2022 and later soared 505.36% in 2025.
  • Year by year, Exchange Rate Effect stood at -$49000.0 in 2021, then surged by 416.33% to $155000.0 in 2022, then rose by 29.03% to $200000.0 in 2023, then crashed by 164.0% to -$128000.0 in 2024, then soared by 40.62% to -$76000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for NVCR at -$76000.0 in Q4 2025, -$22000.0 in Q3 2025, and $265000.0 in Q2 2025.